Skip to content
Open access

Sequential Mitochondrial Transplantation Abrogates Agmatine-Mediated Neuroprotection Against 6-OHDA Toxicity in SH-SY5Y Cells

Oct 2026 · The European Research Journal · pp. 1-11 · 0 citations · 2 references

TL;DR

Postinjury agmatine rescued 6-OHDA-induced viability loss, but sequential MitoTr followed by agmatine caused an additional marked reduction in viability rather than synergistic neuroprotection, underscoring the need for optimized protocols and nonmalignant models.

Abstract

Objective: Parkinson disease (PD) involves dopaminergic neuron loss from mitochondrial dysfunction and oxidative stress. We investigated the combined, sequential effects of mesenchymal stem cell–derived mitochondrial transplantation (MitoTr) and pharmacological agmatine modulation in a PD–like undifferentiated SH-SY5Y cellular model. Methods: Undifferentiated SH-SY5Y cells were exposed to 6-hydroxydopamine (6-OHDA; 350 μM) for 24 hours and sequentially treated with mitochondria (5 or 10 μg/mL) and agmatine (100 μM; 2 hours post-MitoTr). Cell viability was assessed via MTT assays (n = 8 independent experiments). Total-lysate cytochrome c ELISA (n = 3) and Western blots for DJ-1, REDD1, and α-synuclein (n = 4) were performed across 4 core groups. Results: 6-OHDA significantly reduced viability compared with Control (mean [SEM], 0.50 [0.05] vs 1.00 [0.04]; P < .001); postinjury agmatine restored it to near-control levels (mean [SEM], 0.97 [0.20]; P < .001\) vs 6-OHDA), while agmatine alone had no effect (P > .99). Conversely, MitoTr-containing groups showed significantly lower viability than Control, Agmatine, and Agmatine + 6-OHDA groups (P < .001). Most MitoTr arms fell significantly below 6-OHDA alone (P < .05), except the 5 μg/mL triple group (P = .13). Expression of DJ-1, REDD1, and α-synuclein decreased numerically relative to Control without statistical significance (P > .05). Total-lysate cytochrome c was significantly elevated only in the triple-combination group compared with the Control group (mean [SEM], 36.01 [3.65] versus 22.63 [1.08] ng/mL; P = .03). Conclusions: Postinjury agmatine rescued 6-OHDA-induced viability loss, but sequential MitoTr followed by agmatine caused an additional marked reduction in viability rather than synergistic neuroprotection. Molecular alterations remained exploratory and nonsignificant. This MitoTr-associated loss may reflect antiproliferative effects in neuroblastoma-derived cells, underscoring the need for optimized protocols and nonmalignant models.

Read PDF

Similar papers

Open access Nov 2026

Mechanisms Mediating Mancozeb-Induced Toxicity in SH-SY5Y Cells: Mitochondrial Complex II Impairment, Oxidative Stress and Genotoxicity

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons and associated with both genetic and environmental factors. Among environmental agents, the fungicide mancozeb (MZ) has gained attention due to its potential to induce neuronal damage. However, the mechanisms un...

Suzana da Silva, Ana Luiza dos Praseres de Souza, Natali Silva Cardoso et al. · 0 citations
Open access Sep 2026

Icariside II protects against neuronal injury by modulating PI3K/AKT-dependent mitochondrial dynamics and apoptosis in Alzheimer’s disease models

Introduction Icariside II (ICS II), a major bioactive flavonoid metabolite from Epimedium, has been reported to exert neuroprotective effects, but its role in regulating mitochondrial dysfunction-related neuronal injury in Alzheimer’s disease (AD) has not been fully clarified. Methods In this study, we administered ICS...

Si-Yu Shan, Jia-Ming Bai, Yu Tian et al. · 0 citations
Nov 2026

Salidroside alleviates MPP+-induced injury and mitochondrial fission in PC12 cells by mediating the HDAC6/MST1/MIEF1 axis.

Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the loss of dopaminergic neurons and impaired mitochondrial dynamics. Salidroside (SAL), a natural compound extracted from Rhodiola rosea, possesses antioxidative and anti-inflammatory properties, yet its role in regulating mitochondrial fis...

Rui-Xi Zhao, Li-Fang Chen, Xin Li et al. · 0 citations
Open access 2021

อนตรกรยาของสารพฤกษเคมองคประกอบกำหนดความสามารถของสารสกดรำขาวไรซเบอรรในการปองกนการตายของเซลลประสาท SK-N-SH จากภาวะเครยดออกซเดชน

Aging leads to a progressive impairment of mitochondrial function and/or increased oxidative damage has been suggested to play critical roles in the pathogenesis of the neurodegenerative diseases. Brains have a high metabolic rate and relatively low capacity for cellular regeneration, nerve cells in brain area are part...

Maneerat Itsaramongkhonkan, Wenika Benjapong, J. Sirivarasai et al. · 0 citations
Open access Oct 2026

Post-treatment with Meloxicam Attenuates MPP+-Induced Neurotoxicity via PI3K/Akt-Dependent Maintenance of Mcl-1.

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathway. Current treatments for PD primarily provide symptomatic relief through dopamine replacement; however, no neuroprotective drugs are currently clinically available. Our prev...

Yasuhiro Matsuura, Takayuki Manabe, Tomoko Ohkubo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.